• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性腹水通过激活人卵巢癌细胞中的PI3K/Akt信号通路来抵御TRAIL诱导的细胞凋亡。

Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells.

作者信息

Lane Denis, Robert Véronique, Grondin Roxanne, Rancourt Claudine, Piché Alain

机构信息

Département de Microbiologie et Infectiologie, Faculté de Médecine, Université de Sherbrooke, 3001, 12ième Avenue Nord, Sherbrooke, Canada.

出版信息

Int J Cancer. 2007 Sep 15;121(6):1227-37. doi: 10.1002/ijc.22840.

DOI:10.1002/ijc.22840
PMID:17534891
Abstract

Ascites are commonly found in ovarian cancer patients with advanced disease and are rich in cellular components and growth-promoting factors. The purpose of this study was to assess the effect of malignant ascites on TRAIL-induced apoptosis. We demonstrate that malignant ascites obtained from women with advanced ovarian cancer protect tumor cells from TRAIL- and FasL-induced apoptosis but not against cisplatin-induced apoptosis. This antiapoptotic effect was consistently found among different malignant ascites while nonmalignant peritoneal fluids or conditioned medium from TRAIL-resistant cells failed to protect tumor cells against TRAIL killing. Malignant ascites strongly inhibits TRAIL-induced caspase-3 activation and PARP cleavage. Furthermore, ascites activate PI3K and its downstream target Akt and increases c-FLIP(S) protein levels without affecting ERK phosphorylation status. The antiapoptotic effect of malignant ascites is abrogated by the inhibition of PI3K with LY294002, by a specific inhibitor of Akt and by Akt siRNA. We further show that the pro-survival effect of ascites can be suppressed by down-regulation of c-FLIP(S). Our data indicate that malignant effusions protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway. These findings demonstrate that the tumor microenvironment may contribute to the resistance of ovarian cancer cells to death receptor-induced apoptosis.

摘要

腹水常见于晚期卵巢癌患者,富含细胞成分和生长促进因子。本研究旨在评估恶性腹水对TRAIL诱导的细胞凋亡的影响。我们证明,从晚期卵巢癌女性患者获得的恶性腹水可保护肿瘤细胞免受TRAIL和FasL诱导的细胞凋亡,但不能抵抗顺铂诱导的细胞凋亡。在不同的恶性腹水中均一致发现这种抗凋亡作用,而非恶性腹腔积液或来自TRAIL抗性细胞的条件培养基未能保护肿瘤细胞免受TRAIL杀伤。恶性腹水强烈抑制TRAIL诱导的caspase-3激活和PARP裂解。此外,腹水激活PI3K及其下游靶点Akt,并增加c-FLIP(S)蛋白水平,而不影响ERK磷酸化状态。用LY294002抑制PI3K、Akt特异性抑制剂和Akt siRNA可消除恶性腹水的抗凋亡作用。我们进一步表明,下调c-FLIP(S)可抑制腹水的促生存作用。我们的数据表明,恶性积液通过激活PI3K/Akt途径来保护细胞免受TRAIL诱导的细胞凋亡。这些发现表明,肿瘤微环境可能导致卵巢癌细胞对死亡受体诱导的细胞凋亡产生抗性。

相似文献

1
Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells.恶性腹水通过激活人卵巢癌细胞中的PI3K/Akt信号通路来抵御TRAIL诱导的细胞凋亡。
Int J Cancer. 2007 Sep 15;121(6):1227-37. doi: 10.1002/ijc.22840.
2
Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers.Akt对FLIP(S)的上调作用,一种人胃癌中TRAIL诱导凋亡的可能抑制机制。
Cancer Sci. 2003 Dec;94(12):1066-73. doi: 10.1111/j.1349-7006.2003.tb01402.x.
3
TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2.肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的人血管内皮细胞凋亡由磷脂酰肌醇3激酶/蛋白激酶B(PI3K/Akt)通过细胞FLIP短异构体和Bcl-2进行调控。
J Vasc Res. 2005 Jul-Aug;42(4):337-47. doi: 10.1159/000086599. Epub 2005 Jun 28.
4
The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.倍半萜内酯泽兰内酯通过下调 c-FLIP 表达使乳腺癌细胞对 TRAIL 敏感。
Oncol Rep. 2010 Jan;23(1):229-37.
5
Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation.血清生物活性溶血磷脂通过PI3K/Akt依赖性cFLIP表达和Bad磷酸化来预防TRAIL诱导的细胞凋亡。
Cell Death Differ. 2004 Dec;11(12):1287-98. doi: 10.1038/sj.cdd.4401489.
6
Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation.卵巢癌腹水通过 alphavbeta5 整联蛋白介导的粘着斑激酶和 Akt 激活来保护细胞免受 TRAIL 诱导的细胞死亡。
Oncogene. 2010 Jun 17;29(24):3519-31. doi: 10.1038/onc.2010.107. Epub 2010 Apr 19.
7
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.一种新型选择性AKT药理抑制剂可降低人白血病细胞对化疗药物、肿瘤坏死因子相关凋亡诱导配体(TRAIL)、全反式维甲酸和电离辐射的耐药性。
Leukemia. 2003 Sep;17(9):1794-805. doi: 10.1038/sj.leu.2403044.
8
Differential response of neuroblastoma cells to TRAIL is independent of PI3K/AKT.神经母细胞瘤细胞对TRAIL的不同反应独立于PI3K/AKT。
J Pediatr Surg. 2006 Jun;41(6):1072-80. doi: 10.1016/j.jpedsurg.2006.02.001.
9
Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.潜伏膜蛋白 1 通过激活 PI3K/Akt 信号通路介导鼻咽癌细胞对 TRAIL 诱导的细胞凋亡的抵抗。
Oncol Rep. 2011 Dec;26(6):1573-9. doi: 10.3892/or.2011.1423. Epub 2011 Aug 17.
10
XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.X连锁凋亡抑制蛋白(XIAP)在顺铂诱导的人卵巢上皮癌细胞凋亡过程中调节Akt活性和半胱天冬酶-3依赖性切割。
Cancer Res. 2001 Mar 1;61(5):1862-8.

引用本文的文献

1
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib.克服癌症中的化疗耐药性:克唑替尼的前景。
Cancers (Basel). 2024 Jul 7;16(13):2479. doi: 10.3390/cancers16132479.
2
Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries.利用 TRAIL 诱导的细胞死亡进行癌症治疗:充满惊险发现的漫长之旅。
Cell Death Differ. 2023 Feb;30(2):237-249. doi: 10.1038/s41418-022-01059-z. Epub 2022 Oct 4.
3
Ovarian Cancer Ascites Inhibits Transcriptional Activation of NK Cells Partly through CA125.卵巢癌腹水部分通过CA125抑制自然杀伤细胞的转录激活。
J Immunol. 2022 May 1;208(9):2227-2238. doi: 10.4049/jimmunol.2001095. Epub 2022 Apr 8.
4
2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion.2-羟基雌二醇以 ERK 非依赖的方式克服间充质干细胞介导的卵巢癌细胞铂类化疗耐药。
Molecules. 2022 Jan 26;27(3):804. doi: 10.3390/molecules27030804.
5
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.胆碱激酶α功能障碍克服了卵巢癌细胞对 TRAIL 的耐药性。
J Exp Clin Cancer Res. 2021 Jan 4;40(1):5. doi: 10.1186/s13046-020-01794-6.
6
Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion.黄酮类化合物以磷酸化 ERK1/2 依赖的方式恢复卵巢癌细胞对铂类药物的敏感性。
Int J Mol Sci. 2020 Sep 7;21(18):6533. doi: 10.3390/ijms21186533.
7
Metabolic factors contribute to T-cell inhibition in the ovarian cancer ascites.代谢因素导致卵巢癌腹水中 T 细胞抑制。
Int J Cancer. 2020 Oct 1;147(7):1768-1777. doi: 10.1002/ijc.32990. Epub 2020 Apr 25.
8
Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.卵巢癌患者腹水通过 Akt 依赖性途径刺激人腹膜间皮细胞中 MUC16 粘蛋白的表达和分泌。
BMC Cancer. 2019 Apr 30;19(1):406. doi: 10.1186/s12885-019-5611-7.
9
Role of the body mass index in the genesis of ascites in ovarian cancer: a forensic case and review of the literature.体重指数在卵巢癌腹水形成中的作用:一例法医案例及文献综述
BMJ Case Rep. 2018 Dec 18;11(1):e226491. doi: 10.1136/bcr-2018-226491.
10
DAXX promotes ovarian cancer ascites cell proliferation and migration by activating the ERK signaling pathway.DAXX 通过激活 ERK 信号通路促进卵巢癌腹水细胞的增殖和迁移。
J Ovarian Res. 2018 Oct 18;11(1):90. doi: 10.1186/s13048-018-0462-4.